Immunogenicity Summit
  • Slide 1
  • Slide 2
  • Final Agenda Now Available
About the Summit 

Following year-on-year success, CHI presents their 6th Annual Immunogenicity and Bioassay Summit. We present 3 conferences, 45+ presentations, 15+ breakout discussions, panel discussions, receptions, networking and many posters. Immunogenicity Prediction and Mitigation is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity for Regulatory Success and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of bioassays and immunoassays and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.

Short Courses 
November 16
  • Basics of Immunogenicity Testing for Innovators and Biosimilars
  • Challenges of Immunogenicity Assessment for Innovators and Biosimilars
November 18 
  • Immunogenicity Risk Assessment & Regulatory Strategy
  • Bioassays



  • Access All 3 Conferences for One Price 
  • Network with 250+ Global Attendees 
  • Hear 45+ Scientific Presentations 
  • Learn from FDA, Industry, and Leading Academic Research Centers 
  • Dedicated Exhibit/Poster Viewing 
  • Choose from 4 Short Courses 
  • Interactive Roundtable, Breakout & Panel Discussions 
  • Dedicated Networking Opportunities 
IMN Quotes 
2013 Brochure Cover

Download Brochure 


IMN Podcast iconReducing and Monitoring Bioassay Variability 

2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions